1 Debets R, Hegmans J, Prens EP, et al. The IL-1 system in psoriatic skin: IL-1 antagonist sphere of influence in lesional psoriatic epidermis. J Immunol, 1997, 158:2955-2963.
2 刘玮,赵庆利,Debets R,等.银屑病皮损中IL-1受体拮抗物的蛋白和mRNA表达.临床皮肤科杂志,1999,28:340-342.
3 Dinarello CA. Biologic basis for interleukin-1 in diseases. Blood, 1996, 87:2095-2147.
4 Granowitz EV, Mancilla J, Clark BD, et al. The IL-1 receptor antagonist inhibits IL-1 binding to the type 2 IL-1 receptor. J Biol Chem, 1991, 266:14147-14151.
5 Uyemura K, Yamamura M, Fivenson DF,et al.The cytokine network in lesional and lesion-free psoriatic skin is characterised by a T-helper type 1 cell-mediated response. J Invest Dermatol, 1993,101:701-705.
6 Bonifati C, Carducci M, Mussi A, et al. IL-1 alpha, IL-1 beta and psoriasis:conflicting results in the literature: opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin. J Biol Regul Homeost Agents, 1997, 11:133-136.
7 Terui T, Hirao T, Sato Y,et al. An increased ratio of interleukin-1 receptor antagonist to interleukin-1 alpha in inflammatory skin diseases. Exp Dermatol, 1998, 7:327-334. |
